Women's Health Medicine
Volume 3, Issue 3 , Pages 101-103, 1 May 2006

What is polycystic ovary syndrome?

Stephen Franks FMedSci is Professor of Reproductive Endocrinology at Imperial College Faculty of Medicine, St Mary's and the Hammersmith Hospitals, London, UK. Conflicts of interest: none declared.

Abstract 

This article offers a broad overview of polycystic ovary syndrome (PCOS), including the prevalence, genetic disorder, pathogenesis and metabolic disorder concerned with PCOS. Until recently, the most widely accepted clinical definition of PCOS was the association of hyperandrogenism with chronic anovulation in women without specific underlying disease of the adrenal or pituitary gland. Early descriptions of the syndrome were based on ovarian morphology, but this was not considered an essential requirement for the diagnosis. However, recent application of modern, high-resolution diagnostic ultrasonography has again tipped the balance towards a more morphologically based diagnosis. The diagnostic criteria for PCOS have now been revised and require at least two of the following features: polycystic ovaries; oligo-ovulation or anovulation; clinical and/or biochemical evidence of androgen excess.

Keywords:  polycystic ovary syndrome , folliculogenesis , hyperandrogenism , chronic anovulation

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 9.95 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1744-1870(06)70173-1

doi:10.1383/wohm.2006.3.3.101

Women's Health Medicine
Volume 3, Issue 3 , Pages 101-103, 1 May 2006